WG
ETON icon

Winton Group’s Eton Pharmaceutcials ETON Stock Holding History

Winton Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,304
Closed -$767K – 979
2025
Q3 		$767K Buy
+35,304
New +$586K 0.03% 506

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Winton Group's ETON Position: Q4 2025 in Review

Winton Group sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 35,304 shares — an estimated $767K sold.

Winton Group first reported a position in ETON in Q3 2025 and held it in 1 quarter. The position peaked at $767K in Q3 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

  • Winton Group reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
  • Winton Group sold 35,304 Eton Pharmaceutcials shares in Q4 2025, an estimated $767K.
  • Winton Group first reported a position in Eton Pharmaceutcials in Q3 2025 and held it in 1 quarter.
  • Winton Group's Eton Pharmaceutcials position peaked at $767K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.